Oxford Covid vaccine windfall outweighs rest of sector IP income

Blockbuster payout from landmark Oxford-AstraZeneca jab likely to highlight commercial potential of university-led innovation

Published on
February 1, 2023
Last updated
February 1, 2023
Line of winners holding up their trophies to illustrate Oxford Covid vaccine windfall outweighs rest of sector IP income
Source: Alamy

Register to continue

Why register?

  • Registration is free and only takes a moment
  • Once registered, you can read 3 articles a month
  • Sign up for our newsletter
Please
or
to read this article.

Related articles

Reader's comments (2)

This money needs to be share fairly amongst all universities. If Oxbridge is able to rely on bias in funding and opportunity to benefit from IP monopolies, then their state funding needs cutting. It amazes me how much wine worth a fortune is consumed by Oxbridge academics while other universities in the north of starved of basic funding.
This just adds to inequality and marginalises poorer students who are normally at newer universites that produce more 4* outputs than Oxbridge but just to not get listened to so do not have impact.

Sponsored

Featured jobs

See all jobs
ADVERTISEMENT